<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="absorption, to evaluate their potential applications for the treatment of" exact="metabolic syndrome." post="Lipase, phospholipase, protease, Î±-amylase, Î²-glucosidase, and xanthine oxidase activities"/>
 <result pre="the digestive enzymes and thus a potential new drug for" exact="metabolic syndrome" post="treatment. Funding Deanship of Scientific Research, King Saud UniversityRG-1441-471"/>
 <result pre="Î±-amylase, and xanthine oxidase (XO) [2]. The prevalence of the" exact="metabolic syndrome" post="is increasing to epidemic proportions not only in the"/>
 <result pre="between 20% and 30% of the adult population suffer from" exact="metabolic syndrome" post="[4]. Because of this high prevalence and the consequences"/>
 <result pre="[4]. Because of this high prevalence and the consequences of" exact="metabolic syndrome," post="which is an important contributor to the increase in"/>
 <result pre="extracts from various plants may positively influence different features of" exact="metabolic syndrome" post="and control hyperlipidemia in people with obesity, by directly"/>
 <result pre="phospholipases. According to several studies, digestive enzymes are implicated in" exact="metabolic syndrome" post="components, namely, obesity, hypertension, hyperglycemia, hypertriglyceridemia, and hypercholesterolemia, and"/>
 <result pre="[8]. Considering all these facts and in order to prevent" exact="metabolic syndrome," post="searching a natural drug without undesirable side effects should"/>
 <result pre="extracts on human cell lines, the viability of human MDA-MB-231" exact="breast cancer" post="cells (ATTC, Manassas, VA, USA), Lovo, and HCT-116 cell"/>
 <result pre="on human cell lines, the viability of human MDA-MB-231 breast" exact="cancer" post="cells (ATTC, Manassas, VA, USA), Lovo, and HCT-116 cell"/>
 <result pre="Blood Institute (NHLBI)) [30]. It is safe to assume that" exact="obesity" post="is a public health problem. One of the most"/>
 <result pre="One of the most promising targets to regulate and prevent" exact="obesity" post="is through the inhibition of the digestion and absorption"/>
 <result pre="IB phospholipase A2 gene has previously been associated to human" exact="obesity" post="and diabetes [38] because of the catalytic activity of"/>
 <result pre="IB phospholipase A2 deficiency protects against high-carbohydrate diet-induced hyperlipidemia and" exact="obesity" post="in mice [40]. Remarkably, the secretion of this enzyme"/>
 <result pre="be a viable option for a potential therapy to suppress" exact="obesity" post="and diabetes [41], hence the importance to discover new"/>
 <result pre="may confirm their potential use as a natural drug against" exact="obesity" post="and diabetes. Metabolic syndrome is one of the greatest"/>
 <result pre="carbohydrate hydrolyzing enzymes such as Î±-amylase and Î²-glucosidase to prevent" exact="metabolic syndrome." post="As shown in Figure 3, the inhibitory effect of"/>
 <result pre="even though it may reduce calorie intake because of the" exact="suppression" post="of digestive proteolytic activities during gastrointestinal transit. Digestion of"/>
 <result pre="use of E. cyparissias extracts as a therapeutic drug for" exact="metabolic syndrome" post="or other related disease. In vivo and clinical studies"/>
 <result pre="drug may be a promising alternative to prevent and treat" exact="metabolic syndrome." post="Acknowledgments The authors extend their appreciation to the Deanship"/>
 <result pre="contributes to postprandial hyperglycemiaDiabetes200655493594110.2337/diabetes.55.04.06.db05-128616567514 40HugginsK. W.BoileauA. C.HuiD. Y.Protection against diet-induced" exact="obesity" post="and obesity- related insulin resistance in group 1B PLA2-deficient"/>
</results>
